Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
16,681,212
Number of holders
35
Total 13F shares, excl. options
4,755,804
Shares change
+271,118
Total reported value, excl. options
$27,110,326
Value change
+$1,543,438
Number of buys
17
Number of sells
-11
Price
$5.70

Significant Holders of Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (COYA) as of Q3 2025

39 filings reported holding COYA - Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2025.
Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (COYA) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 4,755,804 shares of 16,681,212 outstanding shares and own 28.5% of the company stock.
Largest 10 shareholders include DME Capital Management, LP (1,646,440 shares), AIGH Capital Management LLC (1,105,622 shares), VANGUARD GROUP INC (836,393 shares), CM Management, LLC (300,000 shares), GEODE CAPITAL MANAGEMENT, LLC (156,845 shares), Dauntless Investment Group, LLC (153,021 shares), BlackRock, Inc. (69,958 shares), CITADEL ADVISORS LLC (65,240 shares), STATE STREET CORP (48,100 shares), and MARSHALL WACE, LLP (41,825 shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.